Symberix
Matthew Redinbo, PhD, Secretary, is a co-founder of Symberix and a Kenan Distinguished Professor at University of North Carolina at Chapel Hill in the Departments of Chemistry, Biochemistry & Biophysics, and Microbiology & Immunology. He was Chair of UNC’s Chemistry Department from 2009-2012. He has authored more than 100 publications based on original research and has been invited by the FDA to discuss the scientific and regulatory aspects of microbiome-targeted therapeutic interventions. Dr. Redinbo earned his BS in Biochemistry and English from University of California Davis and PhD in Biochemistry from University of California Los Angeles.
This person is not in any offices
Symberix
Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them.